• CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics

  • Jun 28 2024
  • Length: 17 mins
  • Podcast

CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics

  • Summary

  • As part of our inaugural CEO series, we're excited to welcome Sherine Chan, the CEO and Co-Founder of Neuroene Therapeutics.

    In this episode, Sherine shares her journey from academia to helming a cutting-edge biotech company. She explores the groundbreaking work her company is pioneering in targeting the powerhouses of cells: mitochondria. Sherine also dives into the influence of the Inflation Reduction Act on the development of small-molecule drugs

    We also discuss:
    • Neuroene Therapeutics' ongoing projects.
    • The critical role of mitochondrial dysfunction in neurological conditions such as epilepsy, Parkinson's, and mitochondrial disorders.
    • Sherine's insights for aspiring entrepreneurs and scientists.
    Show more Show less
activate_WEBCRO358_DT_T2

What listeners say about CEO Series Part 1: Sherine Chan, CEO & Co-founder of Neuroene Therapeutics

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.